Following its launch last year and the subsequent criticism of its position by prominent psychiatrists in the The Times and The Lancet Psychiatry, the Council for Evidence-based Psychiatry (CEP) responded by issuing a challenge to its critics to engage in an open, public debate on psychiatric drug harm. Taking up this challenge, the Institute of Psychiatry at Kings College London […]
The latest prescription figures from the Health and Social Care Information Centre show that the UK is in the midst of a psychiatric drug epidemic. Over 57m prescriptions for antidepressants were issued in England in 2014, enough for one for every man, woman and child. This represents a 7.5% increase since 2013, and over 500% […]
Dr Paula Caplan, associate of the DuBois Research Institute at Harvard University, has written an article exposing historical ties between Dr Allen Frances, lead editor of DSM-IV, and Janssen Pharmaceuticals, a Johnson & Johnson subsidiary and the makers of Risperdal, a second generation antipsychotic. Caplan cites a 2010 court document written by Dr David J Rothman, a […]
Following its launch last year and the subsequent criticism of its position by prominent psychiatrists in the The Times and The Lancet Psychiatry, CEP responded by issuing a challenge to its critics to engage in an open, public debate on psychiatric drug harm. CEP is therefore pleased to announce that Kings College London has agreed to host a […]
Dr Peter Breggin, prominent critic of biological psychiatry and psychiatric medication, has published a new short video summarising the dangerous negative effects of different classes of psychiatric drugs.
Professor Peter Gøtzsche has won first prize in the 2014 BMA book awards in the Basis of Medicine Category with his most recent book, ‘Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare’, published by Radcliffe Publishing. Peter is Director of the Nordic Cochrane Centre and a member of CEP. The BMA reviewer commented as […]
David Nutt and colleagues1 represent a brand of psychiatry that wishes to keep its eyes firmly shut when evidence of harms and lack of effectiveness of favoured biological treatments are found. It is therefore unsurprising they take issue with the Council for Evidence-based Psychiatry for publicising evidence that rarely gets discussed; evidence that would enable people […]
The Lancet Psychiatry today published a letter from members of the Council for Evidence-based Psychiatry. The letter is a response to a previous article in The Lancet Psychiatry entitled “Attacks on antidepressants: signs of deep-seated stigma?” which was contributed by Professor David Nutt, Professor Guy Goodwin and others. CEP’s letter can be seen here (no […]
Professor Peter Gøtzsche has today published an article in The Lancet entitled: ‘Why I think antidepressants cause more harm than good’. It was written in response to an earlier piece by Professor David Nutt, Professor Guy Goodwin and others under the heading: ‘Attacks on antidepressants: signs of deep-seated stigma?’ Gøtzsche’s article can be read here: http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(14)70280-9/fulltext?_eventId=login […]
The BBC’s flagship afternoon news programme ‘PM’ on Radio 4 today includes a debate between Dr James Davies and Professor Sir Simon Wessely, the new President of the Royal College of Psychiatrists, regarding oversubscribing of antidepressants and the need for greater transparency within UK psychiatry. The segment starts at 39 mins 20 secs at the […]
